Discounted Cash Flow Rating
Buy
Return on Equity Rating
Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Sell
C
Graphite Bio, Inc. Common Stock (GRPH)
Biological Products, (no Disgnostic Substances)
Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the company's long-lived assets are based in the United States.
611 GATEWAY BLVD, SUITE 120
SOUTH SAN FRANCISCO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/25/2021
Market Cap
185,193,342
Shares Outstanding
58,000,000
Weighted SO
58,221,760
Total Employees
N/A
Upcoming Earnings
N/A
Beta
0.1960
Last Div
2.0600
Range
3.05-29.82
Chg
-0.0900
Avg Vol
40955
Mkt Cap
185193342
Exch
NASDAQ
Country
US
Phone
650 484 0886
DCF Diff
-0.0735
DCF
3.2535
Div Yield
0.3239
P/S
18.0924
EV Multiple
0.3899
P/FV
0.0757
Div Yield %
32.3899
P/E
-0.1278
PEG
0.0052
Payout
0.0000
Current Ratio
11.4715
Quick Ratio
11.2918
Cash Ratio
10.6076
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
856.1891
CCC
-856.1891
Gross Margin
0.7030
Op Margin
-11.1250
Pretax Margin
-11.4659
Net Margin
-11.4659
Eff Tax Rate
-0.0214
ROA
-0.5401
ROE
-0.5796
ROCE
-0.5739
NI/EBT
1.0000
EBT/EBIT
1.0306
EBIT/Rev
-11.1250
Debt Ratio
0.0007
D/E
0.0008
LT Debt/Cap
0.0008
Total Debt/Cap
0.0008
Int Coverage
21.7445
CF/Debt
-595.3205
Equity Multi
1.0967
Rec Turnover
0.0000
Pay Turnover
0.4263
Inv Turnover
0.0000
FA Turnover
16.3254
Asset Turnover
0.0471
OCF/Share
-19.6858
FCF/Share
-21.9058
Cash/Share
45.2091
OCF/Sales
-9.0729
FCF/OCF
1.1128
CF Coverage
-595.3205
ST Coverage
0.0000
CapEx Coverage
-8.8676
Div&CapEx Cov
-8.8676
P/BV
0.0757
P/B
0.0757
P/S
18.0924
P/E
-0.1278
P/FCF
-1.7920
P/OCF
-0.1615
P/CF
-0.1615
PEG
0.0052
P/S
18.0924
EV Multiple
0.3899
P/FV
0.0757
DPS
1.0300
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Dividend History
Cash Value | Ex-Dividend Date | Declaration Date | Record Date | Pay Date |
---|---|---|---|---|
0.15 | 03/22/2024 | 11/30/-0001 | 11/30/-0001 | 11/30/-0001 |